Similar articles

• [Importance of leukotriene antagonists in asthma therapy raised].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2008 Mar 27;150(13):44-5. MMW Fortschr Med. 2008. PMID: 18522358 German. No abstract available.
• [Interview with Dr. W. Wiebicke, Bremen. To treat early with anti-inflammatory drugs!].

  Wiebicke W. Wiebicke W. MMW Fortschr Med. 2002 Feb 21;144(8):12-3. MMW Fortschr Med. 2002. PMID: 11910814 German. No abstract available.
• Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.

  Dupont L, Potvin E, Korn D, Lachman A, Dramaix M, Gusman J, Peché R; Singulair as Complementary Therapy to Fixed Association in Real life Study Group. Dupont L, et al. Curr Med Res Opin. 2005 Jun;21(6):863-9. doi: 10.1185/030079905X46304. Curr Med Res Opin. 2005. PMID: 15969886
• [Montelukast in the treatment of mild to moderate persistent asthma].

  Bellecoste V, Devouassoux G, Pacheco Y. Bellecoste V, et al. Rev Mal Respir. 2011 Jun;28(6):706-29. doi: 10.1016/j.rmr.2010.12.008. Epub 2011 May 17. Rev Mal Respir. 2011. PMID: 21742233 Review. French.
• Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.

  Colucci R, Fornai M, Tuccori M, Antonioli L, Pasqualetti G, Blandizzi C, Del Tacca M. Colucci R, et al. J Asthma. 2007 Jul-Aug;44(6):411-22. doi: 10.1080/02770900701247178. J Asthma. 2007. PMID: 17654125 Review.